John P. Schmid is of ANAPTYSBIO, INC. Currently has a direct ownership of 52,267 shares of ANAB, which is worth approximately $1.25 Million. The most recent transaction as insider was on Jun 15, 2025, when has been sold 6,030 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.3K
13.04% 3M change
1240.18% 12M change
Total Value Held $1.25 Million

John P. Schmid Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 15 2025
BUY
Exercise of conversion of derivative security
-
6,030 Added 10.34%
52,267 Common Stock
Jan 13 2025
BUY
Exercise of conversion of derivative security
$277,307 $6.55 p/Share
42,337 Added 47.8%
46,237 Common Stock
Jun 15 2024
BUY
Exercise of conversion of derivative security
-
3,900 Added 50.0%
3,900 Common Stock

Also insider at

DSGN
Design Therapeutics, Inc. Healthcare
XERS
XERIS PHARMACEUTICALS INC Healthcare
PSTX
Poseida Therapeutics, Inc. Healthcare
XERS
Xeris Biopharma Holdings, Inc. Healthcare
JPS

John P. Schmid

Carlsbad, CA

Track Institutional and Insider Activities on ANAB

Follow ANAPTYSBIO, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANAB shares.

Notify only if

Insider Trading

Get notified when an Anaptysbio, Inc insider buys or sells ANAB shares.

Notify only if

News

Receive news related to ANAPTYSBIO, INC

Track Activities on ANAB